SEC Form 4 · accession 0001209191-18-009013
Juno Therapeutics, Inc. · JUNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hans Edgar Bishop
Officer — CEO & President · Director
Period of report
Feb 7, 2018
Accepted (ET)
Feb 9, 2018 · 7:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001594864
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 7, 2018 | F | 4,346 | $85.49 | D | 2,564,509 | D | |
| Common StockF2 | Feb 7, 2018 | G | 116,280 | $0.00 | D | 2,448,229 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld by the issuer to satisfy tax withholding obligations on the vesting of restricted stock units.
- F2Represents a bona fide gift of common stock; thus, there is no price associated with this transaction.